IP
IndiaPulse

Ellenbarrie Industrial Gases Limited (ELLEN)

Micro Cap

Chemicals stocks · Micro cap · NSE

Ellenbarrie Industrial Gases Limited is an Indian industrial gas manufacturer with over 50 years of legacy. It supplies a wide range of industrial gases (Oxygen, Nitrogen, Argon, Acetylene, Hydrogen, CO2, Helium, Nitrous Oxide, Specialty Gases) and offers project engineering services. The company operates through Onsite, Bulk, and Packaged models, serving diverse industries like steel, chemicals, healthcare, and manufacturing across India.

₹331.85
+1.40 · +0.42%
Quote04 Sept, 03:59 pm IST
Fundamentals22 Aug 2026 · screener
Score05 Sept, 10:20 pm IST · v4.3-runtime-valuation
Tags15 Aug 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Chemicals P/E 34.2 (n=45)
Data confidence
Fresh enough for analysis
Investor decision lenses

One read, four checks

75+ is strong, 60-74 is usable, 45-59 is mixed, and below 45 needs caution. These are research lenses, not buy/sell instructions.

Mixed fundamentals, management trust is supportive, price trend supports entry, and recent execution is consistent.

Suggested next step
Research, do not rush
The four lenses are not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
FAIR VALUE
55

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Trust
Healthy Trust
78

low confidence · 0/0 claims checked

Technical
Bullish
69

Timing lens: price trend and sector relative strength.

Result consistency
consistent
87

Rolling lens: recent quarterly delivery, not the latest single-result score.

Latest result

Quarter ended 30 Jun 2026

Excellent · 100/100

Rev +18% YoY · PAT +84% YoY · margin expansion · +14% QoQ · operating leverage

Filed 30 Jun 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹99 Cr+17.9%+13.8%
EBITDA₹38 Cr+22.6%+40.7%
Operating margin38.0%+100 bps+700 bps
PAT₹35 Cr+84.2%+52.2%
PAT margin35.4%+1273 bps+891 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Business & thesis

Growth engines, tailwinds/headwinds, and risk radar from management commentary

Business and thesis

Where growth can come from, and what can break the case

Thesis intactReviewed 2026-06-09T05:53:10.882Z
Management commentary snapshot

Ellenbarrie reported strong FY26 performance with Total Income up 12% YoY to INR 3,916 mn and PAT up 25% YoY to INR 1,044 mn. Q4FY26 saw Total Income grow 9% YoY to INR 1,020 mn, but PAT declined 12% QoQ due to one-off items. Core Gases revenue grew 14.2% YoY in FY26 and 8.6% QoQ in Q4FY26, with segment margins expanding.

The core gases business demonstrates robust growth and margin expansion, driven by operational leverage and new capacities. Management's focus on high-return organic projects and strategic acquisitions, coupled with a strong balance sheet, supports future growth. Near-term macro pressures and Argon price volatility are noted, but the overall outlook for FY27 appears positive with new plants commissioning.

Current business mix

Revenue breakup by Industry (Q4FY26)

Latest issuer-disclosed distribution across 6 reported categories.

Businessmix
Pharmaceuticals and Chemicals21.0%
Steel32.0%
Dealer and retail network15.0%
Engineering and infrastructure4.0%
Defence3.0%
Others25.0%
Growth engines

Capacity Utilization Ramp-up

Key growth driver

Merchant plant - Uluberia 2 ramp up progressing well, focus on increasing capacity utilization into FY27.

New On-site Plant Commissioning

New revenue stream

New on-site plant in East India expected operational next month, revenues to start in H2FY27.

New Merchant Plants

Expanding geographic reach

New merchant plants in North India (FY27) and West/Central India (FY28) to be operational.

Strategic Acquisitions

Market consolidation

Consolidate market via acquisition of smaller players and expand product portfolio.

Capacity and execution

East India Onsite Plant

Commissioning soon

320 TPD, expected operational June 2026, revenues to start H2FY27.

North India Bulk Plant

Under development

220 TPD, status H2 2027.

West / Central India Bulk Plant

Planned

Capacity TBD, status FY28e onwards.

Uluberia-2 Bulk Plant

Recently commissioned

220 TPD, commissioned in FY26, ramp-up progressing.

Tailwinds

Industrial Gases Market Growth

Sectoral tailwind

Expected to grow at ~7.5% CAGR from 2024 to 2028, backed by end-use industries.

End-use Sector Demand

Diversified demand drivers

Rising demand from chemicals, steel, healthcare, and pharma sectors.

Argon Price Recovery

Product price improvement

Argon prices recovered in H2FY26, momentum expected to continue into FY27.

Headwinds

Argon Price Softness

Impacted profitability

FY26 margins impacted by softness in Argon prices in H2FY26.

Broader Macro Environment

External economic pressure

Industrial activity faces some near-term pressure from the broader macro environment.

Project Engineering Revenue Decline

Strategic shift impact

Project engineering (non-core) revenue declined 62% as division refocused on internal execution.

Risk radar

Input Cost Volatility

Generic industry risk

Changes in international oil prices and input costs can affect ability to implement business strategies.

Intense Competition

Market structure risk

Risk and uncertainties regarding intense competition and pricing environment in the market.

Regulatory Environment Changes

External policy risk

Changes in regulatory environments and new or changed priorities of trade.

One-off Items Impact

Quarterly earnings volatility

Q4FY26 EBITDA margin weighed down by one-off items (employee leave, impairment, settlement).

Management accountability

What management said, and what results must prove

Management accountability

What management said, and what results must prove

Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.

Analyst reading lens
Compare BOTH

The presentation provides both YoY and QoQ comparisons for Q4FY26, which is crucial for understanding both annual growth trends and sequential momentum, especially for core gases revenue and margins, and the impact of one-off items in the quarter.

Sector KPIs management disclosed

Total Income (FY26)

Up 12% YoY

INR 3,916 mn

PAT (FY26)

Up 25% YoY

INR 1,044 mn

Core Gases Revenue Growth (FY26)

Strong growth

14.2% YoY

Core Gases Segment Margin (Q4FY26)

Expanded from 34.6% QoQ

40.0%

Management forward view

Focus on Capacity Utilization

Operational efficiency

Continue to focus on increasing capacity utilization further into FY27 for Uluberia 2.

New Plant Commissioning

Execution of expansion

New on-site plant in East India expected operational next month, revenues to start in H2FY27.

Strategic Capex

Disciplined capital allocation

Reinvest in high-return organic projects (ROCE >15%) and fund new growth initiatives.

Maintain Net-Cash Balance Sheet

Financial prudence

Preserve a net-cash balance sheet for capex flexibility.

Thesis monitor

Numbers and claims to verify in the next filings

CheckpointCurrent evidenceWhat to verify next
Uluberia 2 Capacity UtilizationRamp-up progressing well.Further increase in utilization rates into FY27.
East India On-site Plant RevenueExpected to start in H2FY27.Timely commissioning and revenue contribution.
Adjusted EBITDA Margin35% for Q4FY26 (ex-one-offs).Sustained margin levels and recovery from Argon price softness.
New Plant Capex ExecutionFY27e: INR 2500 mn, FY28e: INR 2000 mn.Adherence to capex guidance and commissioning timelines.

Verification checkpoints are IndiaPulse research interpretation, not investment advice.

Technical timing lens

Trend score and candlestick chart

69Bullish

full bull SMA stack · SMA20 +13.9% / mo · MACD −

Stock trend: 77
Sector RS: 57
Sector 3M: +0.0% vs Nifty -1.5%

Technical chart

ELLENdaily · 1Y · AUTO+52.8%
Latest close ₹331.85 on 2026-09-04
Bar
-0.6%
RSI
62
MACD hist
-0.90
52W pos
41%
2026-09-04O ₹333.80H ₹340.15L ₹327.50C ₹331.85Vol 7.6L sh
₹166.55₹213.01₹259.48₹305.94₹352.4052L331.852026-032026-06VolRSIMACD2026-032026-042026-062026-072026-09
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal

Daily technical trend read

Bullish setup

Trend is constructive — long-term uptrend intact. RSI 62.

  • Price > SMA20 > SMA50 > SMA200 — full bullish stack.
  • Recent golden cross (SMA50 crossed above SMA200).
  • SMA20 rising (~12.2% over last month) — short-term momentum positive.
  • RSI(14) at 62 — rising, no extreme reading.
  • MACD below signal but histogram contracting — bearish momentum easing.
  • 41% off 52W high · 90% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Valuation & score drivers

U-Score 55 · FAIR VALUE · pillar breakdown, sector model, fair-value anchor

55U-SCORE
Financial Turnaround

Fundamental score breakdown

FAIR VALUE
Valuation4/30
Growth23/25
Quality9/20
Balance Sheet10/15
Cash Flow4/10
Piotroski
8/9 (+5)
Penalties
0
Raw sum
55

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

55/100 · FAIR VALUE

Positive drivers

  • Piotroski is strong at 8/9.
  • Fair-value margin of safety is positive at 13.8%.
  • Growth contributes 23/25 to the score.

Main drags

  • Valuation is weaker at 4/30; verify the latest quarterly trend.
  • Cash flow is weaker at 4/10; verify the latest quarterly trend.
  • Quality is weaker at 9/20; verify the latest quarterly trend.
Sector valuation model

Cyclical valuation: normalized earnings, not just trailing PE

Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.

Cyclical normalized
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
38.4
PB
4.7
EV/EBITDA
33.0
ROE
14.2%
ROCE
15.2%
FCF Yield
Debt/Equity
0.2
MoS
+13.8%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 05 Sept 2026
v4.3-runtime-valuation
Final score
55
Previous: 55
Verdict
FAIR VALUE
Previous: FAIR VALUE
Margin of safety
+13.8%
Previous: +13.8%

Score history

12 stored score snapshots. Latest stored move: -1 points.

05 Sept 2026
v4.3-runtime-valuation
57
53
56
56
55
55
56
56
56
56
56
55

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.

Modelled fair value

Graham Number
₹115.53
-187.2% MoS
Growth-justified P/E
45.0
Growth-justified Value
₹385.2
+13.8% MoS
PEG
0.80

Trust score

Does management behaviour match later outcomes? Claim delivery, forensic breakdown, evidence depth

Trust Score
78Healthy Trust · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Healthy Trust: Claim history is still being built. It ranks around the 86th percentile of the scored universe and 77th percentile within Chemicals. No major sub-score weakness stands out.

High Trust Lite: Promoter holding is 77.2%.

Computed 05 Sept 2026
management-trust-v1
21 docs text-extracted · 8 concalls text-extracted
Score band
Healthy Trust

Generally investable credibility. Look for weak sub-scores before increasing position size.

Relative rank
86th percentile

overall median 67 · Chemicals: 77th pctile, median 73 · Micro: 74th pctile, median 73

Evidence depth
Financial-only

21 documents have extracted text, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Healthy Trust · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Can support position sizing if valuation and trend also agree.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
86
strong · holding, pledge, alignment
Cash flow
67
acceptable · profit to cash conversion
Balance sheet
89
strong · leverage and solvency
Discipline
68
acceptable · capital discipline
Results
87
strong · quarterly consistency

Trust positives

  • Promoter holding is 77.2%.
  • Promoter pledge is zero.
  • 4 years of positive FCF.
  • 3/4 latest quarters had positive YoY revenue growth.

Trust risks

  • No major Trust Lite risk flags.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Financials

Full fundamentals table and 10-year revenue / profit / ROE history

Fundamentals

Valuation

P/E
38.40
P/B
4.73
EV/EBITDA
32.97
Market Cap
4630.00Cr

Profitability

ROE
14.20%
ROCE
15.20%
ROA
9.31%
Dividend Y

Growth (CAGR)

Revenue 5Y
14.00%
EPS 5Y
34.00%
Revenue 3Y
19.00%
EPS 3Y
69.00%

Balance Sheet

Debt/Equity
0.19
Interest Coverage
17.57×
Altman Z
7.88
Book Value
69.30

Cash Flow

FCF Yield
FCF Positive Y
4/5
OCF
133.00 Cr
EPS TTM
8.56

Shareholding

Promoter Hold
77.15%
Promoter Pledge
0.00%
Momentum 52W
40%

Financial History

Updated 5/9/2026

Revenue

₹ Cr
No data

Net Profit

₹ Cr
No data

Return on Equity

%
No data

Peers

Business-comparable names in Chemicals, ranked by similarity

Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.